Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Vnitrni Lekarstvi|May 28, 1998
[Plasminogen activator inhibitor (PAI-1) and diabetes mellitus. I. Regulation of PAI-1 levels]P Galajda, L Sutarík, L Vladár, et al.
Bratislavske Lekarske Listy|September 1, 1992
[Endogenous digitalis-like substance in relation to glycemia and insulinemia]E Martinka, M Ochodnický, J Kvĕtenský, et al.
Vnitrni Lekarstvi|October 1, 1996
[Hemostasis in patients with diabetes mellitus. I. Markers of endothelial dysfunction]P Galajda, E Martinka, P Kubisz, et al.
Bratislavske Lekarske Listy|October 1, 1989
[Serum ferritin, its clinical significance and our personal experience]E Galajdová, P Galajda, J Holan, et al.
Vnitrni Lekarstvi|November 1, 1996
[Hemostasis in patients with diabetes mellitus. II. Tissue factor and the extrinsic blood coagulation inhibitor]P Galajda, E Martinka, P Kubisz, et al.
Vnitrni Lekarstvi|August 1, 1992
[Immunologic indicators in ascites]L Vladár, M Mokán, J Kvĕtenský, et al.
Vnitrni Lekarstvi|June 18, 2013
[Paraneoplastic hypoglyacemia]I Ságová, A Klimentová, D Prídavková, et al.
Bratislavske Lekarske Listy|August 31, 2018
The role of proteinuria, paricalcitol and vitamin D in the development of post-transplant diabetes mellitusI Dedinska, L Laca, J Miklusica, et al.
Vnitrni Lekarstvi|July 3, 1998
[Plasminogen activator inhibitor (PAI-1) and markers of endothelial dysfunction in patients with diabetes mellitus]P Galajda, E Martinka, D Baláz, et al.
Thrombosis and Haemostasis|October 5, 2001
Increased platelet glycoprotein V levels in patients with coronary and peripheral atherosclerosis--the influence of aspirin and cigarette smokingA D Blann, F Lanza, P Galajda, et al.
Pageof 4